Civil Litigation,
Health Care & Hospital Law,
Government
Jun. 6, 2019
Opioid maker settles with DOJ for $225M
Opioid manufacturer Insys Therapeutics agreed to a $225 million global settlement with the government after admitting to paying doctors kickbacks to promote the drug Subsys, a highly addictive fentanyl spray, the Department of Justice announced Wednesday.
Opioid manufacturer Insys Therapeutics agreed to a $225 million global settlement with the government after admitting to paying doctors kickbacks to promote the drug Subsys, a highly addictive fentanyl spray, the Department of Justice announced Wednesday.
The U.S. attorney's office in Massachusetts charged Insys and its subsidiary with five counts of mail fraud. According to the charging document, after the drug was approved by th...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In